# New York Blood Center Enterprises – FDA Inspection, Mar 23, 2010

Source: https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/efb67d6e-e903-46bb-8662-9bd709b4ffe7
Source feed: FDA_Inspections

> FDA inspection 651951 of New York Blood Center Enterprises, March 23, 2010. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR parts 211 and 606. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 651951
- Company Name: New York Blood Center Enterprises
- Inspection Date: 2010-03-23
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1209368 - 2023-07-06](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/9c164be7-dd86-4215-8cb0-e3ba7a8e0d05)
- FDA Inspection 983888 - 2016-08-17
- [FDA Inspection 901033 - 2014-10-28](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/2f550a0e-864a-48a9-b402-03154e9b25f7)
- [FDA Inspection 812875 - 2013-01-15](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/26dfa2f6-7368-4e1f-aa5f-703998cdd1ff)

Company: https://www.keypedia.com/companies/new-york-blood-center-enterprises/694e089d-d144-4b01-8785-e04f23f49d56

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
